Articles by Farshid Dayyani, MD, PhD
The panel concludes with a discussion on treatment strategies for metastatic esophageal squamous cell carcinoma.
The panel shifts focus to the 1L treatment of metastatic gastroesophageal cancers, exploring biomarker testing strategies.
The panel delves into the implications of recent data on IO in the perioperative, adjuvant treatment of upper GI cancers.
The panel takes a deep dive into the evolving role of IO in resectable GE cancer, with a focus on the results of MATTERHORN.
The panel launches into a discussion of practice-changing data, focusing on MATTERHORN and its impact on disease management.
630 Madison Ave.
Manalapan, NJ 07726
About Column
Contribute Column
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.